| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| GRB10 | IGF1 | ENSMMUP00000026288 | ENSMMUP00000002988 | Uncharacterized protein. | Insulin like growth factor 1. | 0.702 |
| GRB10 | IGF1R | ENSMMUP00000026288 | ENSMMUP00000016141 | Uncharacterized protein. | Tyrosine-protein kinase receptor. | 0.990 |
| GRB10 | IGF2 | ENSMMUP00000026288 | ENSMMUP00000075297 | Uncharacterized protein. | Insulin like growth factor 2. | 0.608 |
| GRB10 | INS | ENSMMUP00000026288 | ENSMMUP00000037777 | Uncharacterized protein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.663 |
| GRB10 | INSR | ENSMMUP00000026288 | ENSMMUP00000045695 | Uncharacterized protein. | Insulin receptor subunit alpha; Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lea [...] | 0.870 |
| GRB10 | IRS1 | ENSMMUP00000026288 | ENSMMUP00000045227 | Uncharacterized protein. | Insulin receptor substrate 1. | 0.619 |
| GRB10 | IRS2 | ENSMMUP00000026288 | ENSMMUP00000028694 | Uncharacterized protein. | Insulin receptor substrate 2. | 0.514 |
| GRB10 | SHC1 | ENSMMUP00000026288 | ENSMMUP00000008658 | Uncharacterized protein. | SHC-transforming protein 1 isoform 3. | 0.411 |
| GRB14 | IGF1R | ENSMMUP00000020055 | ENSMMUP00000016141 | Growth factor receptor bound protein 14. | Tyrosine-protein kinase receptor. | 0.695 |
| GRB14 | INS | ENSMMUP00000020055 | ENSMMUP00000037777 | Growth factor receptor bound protein 14. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.594 |
| GRB14 | INSR | ENSMMUP00000020055 | ENSMMUP00000045695 | Growth factor receptor bound protein 14. | Insulin receptor subunit alpha; Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lea [...] | 0.918 |
| GRB14 | SHC1 | ENSMMUP00000020055 | ENSMMUP00000008658 | Growth factor receptor bound protein 14. | SHC-transforming protein 1 isoform 3. | 0.474 |
| IGF1 | GRB10 | ENSMMUP00000002988 | ENSMMUP00000026288 | Insulin like growth factor 1. | Uncharacterized protein. | 0.702 |
| IGF1 | IGF1R | ENSMMUP00000002988 | ENSMMUP00000016141 | Insulin like growth factor 1. | Tyrosine-protein kinase receptor. | 0.999 |
| IGF1 | IGF2 | ENSMMUP00000002988 | ENSMMUP00000075297 | Insulin like growth factor 1. | Insulin like growth factor 2. | 0.975 |
| IGF1 | INS | ENSMMUP00000002988 | ENSMMUP00000037777 | Insulin like growth factor 1. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.993 |
| IGF1 | INSR | ENSMMUP00000002988 | ENSMMUP00000045695 | Insulin like growth factor 1. | Insulin receptor subunit alpha; Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lea [...] | 0.970 |
| IGF1 | IRS1 | ENSMMUP00000002988 | ENSMMUP00000045227 | Insulin like growth factor 1. | Insulin receptor substrate 1. | 0.930 |
| IGF1 | IRS2 | ENSMMUP00000002988 | ENSMMUP00000028694 | Insulin like growth factor 1. | Insulin receptor substrate 2. | 0.867 |
| IGF1 | SHC1 | ENSMMUP00000002988 | ENSMMUP00000008658 | Insulin like growth factor 1. | SHC-transforming protein 1 isoform 3. | 0.612 |